GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGS
GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGS
批准号:
6658022
负责人:
DAVID J GREENBLATT
金额:
$35.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2005-05-31
关键词:
AIDS therapy HIV infections P glycoprotein SDS polyacrylamide gel electrophoresis alternative medicine angiosperms antiAIDS agent antiviral agents biological products blood chemistry clearance rate clinical research combination therapy cytochrome P450 drug interactions drug metabolism enzyme induction /repression human subject midazolam pharmacokinetics physical chemical interaction protein isoforms ritonavir saquinavir tissue /cell culture western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The use of complementary and alternative medical (CAM) therapies, including botanical medicines, is increasing continuously. Botanical medicines are of particular importance, since these natural preparations may cause clinically important drug interactions with prescription drugs, in particular the antiretroviral drugs that have become the principal medical treatment for individuals with HIV infection and AIDS. This population commonly uses additional CAM treatments, including botanical medicines. Garlic is commonly taken by patients with HIV, and garlic has been shown to interact with saquinavir. The broad objective of this project is to develop and test research models to enhance mechanistic understanding of interactions between botanicals and antiretrovirals, such that clinically important interactions can be anticipated and prevented. We propose a combined experimental and clinical approach to evaluating the influence of garlic, and of selected chemical components of garlic, on the processes regulating disposition of the majority of antiretroviral agents (metabolism by CYP3A and transport by P-glycoprotein), and on the pharmacokinetics of two representative antiretrovirals, ritonavir and saquinavir. There are two specific aims. The experimental component will assess the effect of two garlic preparations (standardized garlic and aged garlic extract), and several individual chemical components, in the following systems: inhibitory actions on human CYP3A (and other CYPs) in human liver microsomes; induction of CYP3A in primary human hepatocyte culture; inhibition of P-gp transport in Caco-2 transwell cultures; and induction of P-gp expression in LS180V transwell cell cultures. In clinical studies of healthy human volunteers, we will study the effect of 14 days of exposure to standardized garlic, aged garlic extract, and placebo on: the clearance of oral midazolam, a CYP3A probe substrate; the clearance of oral fexofenadine, a probe P-gp substrate; and the pharmacokinetics of ritonavir and saquinavir, representative antiretrovirals dependent on CYP3A and P-gp for disposition and clearance. Kinetics of these compounds are determined prior to, during, and after garlic exposure. The work will provide immediately applicable clinical data on garlic interactions with antiretrovirals, as well as mechanistic data identifying the interaction process and its predictability from in vitro models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COLLABORATORY EXTENSION TO CHIMERA
-
批准号:7180218
-
项目类别:
-
资助金额:$5.64万
-
财政年份:2005
-
负责人:DAVID J GREENBLATT
-
依托单位:
COLLABORATORY EXTENSION TO CHIMERA
-
批准号:6976082
-
项目类别:
-
资助金额:$9.36万
-
财政年份:2004
-
负责人:DAVID J GREENBLATT
-
依托单位:
MDR1 and Related Proteins during HIV PI Exposure
-
批准号:6954257
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:DAVID J GREENBLATT
-
依托单位:
CX516 (Ampalex) in Healthy Elderly Males and Females
-
批准号:7040667
-
项目类别:
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:DAVID J GREENBLATT
-
依托单位:
CYP3A Function in Aging AfricanAmericans
-
批准号:6475200
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
CYP3A Function in Aging AfricanAmericans
-
批准号:7047743
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
CYP3A Function in Aging AfricanAmericans
-
批准号:6730520
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGS
-
批准号:6760108
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
CYP3A Function in Aging AfricanAmericans
-
批准号:6896140
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGS
-
批准号:6582651
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
CYP3A Function in Aging AfricanAmericans
-
批准号:6624456
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2002
-
负责人:DAVID J GREENBLATT
-
依托单位:
HAART Regimens in Substance Abusers
-
批准号:6450988
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
Metabolic Consequences of HAART: CYP3A and P-gp
-
批准号:6347096
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
HAART Regimens in Substance Abusers
-
批准号:6523286
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
Metabolic Consequences of HAART: CYP3A and P-gp
-
批准号:6635316
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
HAART Regimens in Substance Abusers
-
批准号:6655137
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
Metabolic Consequences of HAART: CYP3A and P-gp
-
批准号:6517824
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2001
-
负责人:DAVID J GREENBLATT
-
依托单位:
ANTIRETROVIRAL THERAPIES AND SUBSTANCE ABUSE
-
批准号:6286930
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2000
-
负责人:DAVID J GREENBLATT
-
依托单位:
ANTIRETROVIRAL THERAPIES AND SUBSTANCE ABUSE
-
批准号:6523192
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2000
-
负责人:DAVID J GREENBLATT
-
依托单位:
ANTIRETROVIRAL THERAPIES AND SUBSTANCE ABUSE
-
批准号:6379020
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2000
-
负责人:DAVID J GREENBLATT
-
依托单位:
海外基金